Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.657,33
1,22%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Genmab AS (GMAB) Genmab AS (GMAB) Notizie

Genmab AS

GMAB
29,73
2,01 (7,25%)
04 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
30/4/202400:40BWFDA Grants Full Approval for TIVDAK® to Treat Recurrent or..
03/4/202407:35BWGenmab to Broaden and Strengthen Oncology Portfolio with..
11/3/202418:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/3/202419:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/3/202419:26EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/3/202423:04EDGAR2Form 144 - Report of proposed sale of securities
29/2/202417:47EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/2/202417:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/2/202422:55EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/2/202413:45BWU.S. FDA Accepts for Priority Review the Supplemental..
26/2/202418:19EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/2/202416:40EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/2/202422:28EDGAR2Form S-8 - Securities to be offered to employees in employee..
20/2/202417:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/2/202421:42EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/2/202419:49EDGAR2Form 20-F - Annual and transition report of foreign private..
14/2/202418:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/2/202412:45BWTisotumab Vedotin Marketing Authorization Application..
31/1/202417:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/1/202415:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/1/202413:45DJNPfizer, Genmab Get Speedy FDA Review of Tivdak Full Approval
09/1/202412:45BWTIVDAK® (tisotumab vedotin-tftv) Supplemental Biologics..
03/1/202414:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/12/202317:46EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/12/202318:00BWNew Pivotal Data for Bispecific Antibody Epcoritamab..
01/12/202319:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/11/202313:00BWGenmab Announces Positive Regulatory Updates for Epcoritamab..
21/11/202322:51EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/11/202316:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/11/202318:24EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/11/202317:12EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/11/202314:05BWGenmab Announces Multiple Abstracts to be Presented at the..
22/10/202316:30BWTIVDAK® (tisotumab vedotin-tftv) Significantly Prolonged..
17/10/202314:22EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/10/202316:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/9/202322:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/9/202314:53EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/9/202314:50DJNAbbVie, Genmab Get Conditional Europe OK of Tepkinly..
25/9/202313:45BWGenmab Announces European Commission Approval of TEPKINLY®..
25/9/202311:55BWEPKINLY™ (epcoritamab) Approved by Japan Ministry of Health,..
13/9/202315:59EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/9/202321:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/9/202315:12EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/9/202321:00BWSeagen and Genmab Announce TIVDAK® (tisotumab vedotin-tftv)..
16/8/202319:44EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/8/202321:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/8/202317:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/7/202315:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/7/202310:30BWGenmab Announces AbbVie Receives Positive CHMP Opinion for..
20/7/202315:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
Apertura: 29,73 Min: 29,46 Max: 29,92
Chiusura: 27,72

La tua Cronologia

NASDAQ
GMAB
Genmab AS
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network